Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PGEN
PGEN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PGEN News
Precigen Secures Orphan Drug Exclusivity for PAPZIMEOS
Jun 15 2026
Newsfilter
Precigen CFO Sells Shares, Ownership Stake Decreases
Jun 12 2026
Fool
Biotech Companies See Significant Stock Gains
Jun 12 2026
NASDAQ.COM
Precigen Collaborates with RRPF to Raise RRP Awareness
Jun 11 2026
PRnewswire
Precigen Releases Long-Term Data on PAPZIMEOS for RRP Treatment
May 30 2026
PRnewswire
Precigen Reports Long-Term Follow-Up Data on PAPZIMEOS for RRP
May 30 2026
Newsfilter
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS
May 27 2026
PRnewswire
Precigen to Participate in Upcoming Investor Events
May 26 2026
PRnewswire
Precigen Reports Strong Q1 2026 Earnings, Shares Surge
May 14 2026
seekingalpha
Citizens Raises Precigen Price Target to $11 Amid Strong Sales
May 14 2026
stocktwits
Precigen Inc Reports Strong Q1 2026 Revenue Growth
May 14 2026
Yahoo Finance
Precigen Reports Strong Q1 2026 Earnings with $21.6M in Revenue
May 14 2026
seekingalpha
Precigen Q1 Earnings Preview and Outlook
May 12 2026
seekingalpha
Precigen's PAPZIMEOS Sees Strong Sales Growth
Apr 08 2026
Yahoo Finance
Precigen to Participate in H.C. Wainwright Virtual Fireside Chat
Mar 30 2026
PRnewswire
Precigen to Participate in Virtual Fireside Chat
Mar 30 2026
Newsfilter
Show More News
